August 26, 2025
Article
The FDA granted breakthrough device designation to Quest Diagnostics’ Haystack MRD test for patients with stage 2 colorectal cancer after surgery.
December 05, 2023
Video
The panel concludes their discussion with a conversation about the myths surrounding the treatment of cervical cancer.
Experts on cervical cancer offer provide comprehensive insights on the challenges patients experience and discuss ways to improve care.
November 29, 2023
Linda Ryan, a recurrent cervical cancer survivor and patient advocate, offers advice for patients undergoing cervical cancer treatment on advocating for yourself and communicating with family.
Finding Credible Voices in the Lynch Syndrome Community
Understanding Your Stage 2 Lymphoma Diagnosis
FDA Approves Revuforj for R/R NPM1-Mutant AML
How Does FDA-Approved Blenrep Treat Multiple Myeloma?